Neville Everett sold 617 Cigna Group shares at $284.05 each. The transaction leaves Everett with 5,053 Cigna Group shares, giving investors a precise view of the reported change in his holdings and the balance remaining following the transaction.
Key Highlights
- Transaction code S classified the Sep 3, 2026 event as a sale.
- Neville Everett owned 5,053 Cigna Group shares after the transaction.
- Everett was identified as “See Remarks” for Cigna Group.
Cigna Group (NYSE: CI) shares were sold by Neville Everett, who disposed of 617 shares at $284.05 per share. The transaction left Everett holding 5,053 Cigna Group shares.
Transaction Code S Identifies Share Sale
The transaction occurred on 3 September 2026. The reported price was $284.05 for each of the 617 shares sold. The post-transaction position was 5,053 Cigna Group shares. These figures describe the reported sale and Everett’s resulting holdings.
FAQs
Q: How many Cigna Group shares did Neville Everett sell?
A: Neville Everett sold 617 Cigna Group shares at $284.05 per share. The transaction took place on 3 September 2026 and carried transaction code S.
Q: What happened to Cigna Group shares after the sale?
A: Neville Everett owned 5,053 Cigna Group shares after the reported transaction. The sale involved 617 shares at a price of $284.05 each.
Q: What does transaction code S mean for the Cigna Group transaction?
A: Transaction code S identifies the transaction as a share sale by Neville Everett at Cigna Group. The reported sale involved 617 shares on 3 September 2026 at $284.05 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.